Tizanidine
- Product NDC
- 68788-7782
- 11-digit product format
- 687887782
- Labeler code
- 68788
- Product ID
- 68788-7782_158c1c11-abb2-495f-938e-c8baa677f4c5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2020-10-20
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7782-3 | 68788778203 | 30 TABLET in 1 BOTTLE, PLASTIC (68788-7782-3) | 30 tablet | 2020-10-20 | 0000-00-00 | No | No | Current |
| 68788-7782-6 | 68788778206 | 60 TABLET in 1 BOTTLE, PLASTIC (68788-7782-6) | 60 tablet | 2020-10-20 | 0000-00-00 | No | No | Current |
| 68788-7782-8 | 68788778208 | 120 TABLET in 1 BOTTLE, PLASTIC (68788-7782-8) | 120 tablet | 2020-10-20 | 0000-00-00 | No | No | Current |
| 68788-7782-9 | 68788778209 | 90 TABLET in 1 BOTTLE, PLASTIC (68788-7782-9) | 90 tablet | 2020-10-20 | 0000-00-00 | No | No | Current |